Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Clinical trial NCT02866032 · COMPLETED
Trial details
- NCT number
- NCT02866032
- Sponsor
- Moberg Pharma AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2020-06-10
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.